Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
Treatment options for metastatic melanoma are limited. Here the authors show that combining an immunostimulant adenovirus, currently in clinical trials for leukemia, with immune checkpoints blockade (ICB) results in systemic eradication of ICB resistant melanoma tumours from both skin and brain of m...
Guardado en:
Autores principales: | Manisha Singh, Christina Vianden, Mark J. Cantwell, Zhimin Dai, Zhilan Xiao, Meenu Sharma, Hiep Khong, Ashvin R. Jaiswal, Faisal Faak, Yared Hailemichael, L. M. E. Janssen, Uddalak Bharadwaj, Michael A. Curran, Adi Diab, Roland L. Bassett, David J. Tweardy, Patrick Hwu, Willem W. Overwijk |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/91b84c7ca48048a5926a4f18a85bbaa3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
por: Meenu Sharma, et al.
Publicado: (2020) -
Trial watch: intratumoral immunotherapy
por: Juliette Humeau, et al.
Publicado: (2021) -
Intratumoral heterogeneity and clonal evolution in liver cancer
por: Bojan Losic, et al.
Publicado: (2020) -
Clinical significance of intratumor heterogeneity for gynecological carcinoma
por: Ying-Chao Yang, et al.
Publicado: (2015) -
Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
por: Sharanya Maanasi Kalasekar, et al.
Publicado: (2021)